Open an account

Masimo

MASI · NASDAQ

Price unavailable right now.

No price history for this range.

About MASI

Masimo Corp. is a global technology company, which engages in the development, manufacture, and marketing of patient monitoring technologies, and automation and connectivity solutions. The company is headquartered in Irvine, California and currently employs 2,200 full-time employees. The company went IPO on 2007-08-08. The Company’s healthcare products and patient monitoring solutions generally incorporate a monitor or circuit board, proprietary single-patient use or reusable sensors, software and/or cables. The company primarily sells its healthcare products to hospitals, emergency medical service providers, home care providers, physician offices, veterinarians, long-term care facilities. Its measurement technologies include Measure-through Motion and Low Perfusion pulse oximetry, known as Masimo Signal Extraction Technology (SET) pulse oximetry, and advanced rainbow Pulse CO-Oximetry parameters such as noninvasive hemoglobin (SpHb), alongside many other modalities, including brain function monitoring, hemodynamic monitoring, regional oximetry, capnography and gas monitoring, and others.

Employees
2,200
Headquarters
Irvine, California
Listed
Aug 8, 2007
Sector
Health Care
Industry
Health Care Equipment & Supplies
Website
masimo.com

MASI key statistics

This section is temporarily unavailable. Refresh to try again.

Analyst ratings

Latest rating from each analyst over the past 12 months

0%of 4 analyst ratings say Buy
  • Buy0.0%
  • Hold100.0%
  • Sell0.0%
Price target · 7 analystsAvg $180.29
Low
$163.62
High
$190.84

MASI earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 7 of the last 8 quarters, by 10.6% on average.

  1. Q1 FY24: reported $0.77 per share against an estimate of $0.7024
  2. Q2 FY24: reported $0.86 per share against an estimate of $0.78
  3. Q3 FY24: reported $0.98 per share against an estimate of $0.8529
  4. Q4 FY24: reported $1.67 per share against an estimate of $1.45
  5. Q1 FY25: reported $1.36 per share against an estimate of $1.23
  6. Q2 FY25: reported $1.33 per share against an estimate of $1.25
  7. Q3 FY25: reported $1.32 per share against an estimate of $1.23
  8. Q1 FY26: reported $1.08 per share against an estimate of $1.46

MASI news

  • Vandana Singh

    Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover

  • Press releasePRNewswire

    Sirius XM Holdings Set to Join S&P MidCap 400

  • Press releaseBusiness Wire

    Masimo Shareholders Approve Acquisition by Danaher

  • Press releaseBusiness Wire

    Masimo SET® Pulse Oximetry Performed Accurately on Hospitalized Newborns of All Skin Tones in Largest-Ever Prospective Real-World Study

  • Mohd Haider

    Masimo's Appeal Rejection, M5 Chip Push, China Smartphone Growth, Foldable iPhone: This Week In Appleverse

  • Ananya Gairola

    Apple Scores Key Win As Trade Commission Rejects Masimo's Bid To Reinstate Apple Watch Import Ban

  • Press releasePRNewswire

    Are MASI, CECO, MPX Obtaining Fair Deals for their Shareholders?

  • Press releaseGlobe Newswire

    Telix Strengthens Board with Additional Director Appointments

Similar companies

Companies in the same industry as Masimo

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.